A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients

IntroductionWe examined the neutralizing antibody production efficiency of the second and third severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine doses (2nd- and 3rd-dose) and neutralizing activity on mutant strains, including, the Ancestral, Beta and Omicron strains using green f...

Full description

Bibliographic Details
Main Authors: Takahiro Tomiyama, Rigel Suzuki, Noboru Harada, Tomokazu Tamura, Katsuya Toshida, Yukiko- Kosai-Fujimoto, Takahiro Tomino, Shohei Yoshiya, Yoshihiro Nagao, Kazuki Takeishi, Shinji Itoh, Nobuhiro Kobayashi, Hayato Ito, Sachiyo Yoshio, Tatsuya Kanto, Tomoharu Yoshizumi, Takasuke Fukuhara
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
SARS-CoV-2
liver transplantation
anti-SARS-CoV-2 vaccination
immunosuppressive treatment
mutant strains
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1197349/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2023.1197349/full

Similar Items